Plus   Neg

Indivior Preliminary FY20 Results Ahead Of Its Guidance - Quick Facts

Pharmaceutical company Indivior (INDV.L) now expects total net revenue for the year ended December 31, 2020 to be in the range of $645 million to $650 million (guidance $595 million to $620 million). The Group currently anticipates its operating expense base to be slightly below guidance of $470 million to $480 million. As a reult, the Group now expects to deliver adjusted pre-tax income ahead of its previous expectations.

Indivior plans to release its fiscal year 2020 results on February 18, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT